Business Description

Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset 0.46
Debt-to-Equity 0.8
Debt-to-EBITDA -0.45
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -16.05
Distress
Grey
Safe
Beneish M-Score 1.3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 28.38
9-Day RSI 37.34
14-Day RSI 41.06
6-1 Month Momentum % -52.49
12-1 Month Momentum % -43.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.13
Quick Ratio 0.13
Cash Ratio 0.06
Days Sales Outstanding 71.97
Days Payable 7967.95

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.2
Shareholder Yield % -10.17

Financials (Next Earnings Date:2024-05-31 Est.)

AGE's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:AGE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

AgeX Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.142
EPS (TTM) ($) -13.754
Beta 0
Volatility % 98.56
14-Day RSI 41.06
14-Day ATR ($) 2.582702
20-Day SMA ($) 14.260566
12-1 Month Momentum % -43.14
52-Week Range ($) 10.902699 - 35.169999
Shares Outstanding (Mil) 2.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AgeX Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

AgeX Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

AgeX Therapeutics Inc Frequently Asked Questions

What is AgeX Therapeutics Inc(AGE)'s stock price today?
The current price of AGE is $11.10. The 52 week high of AGE is $35.17 and 52 week low is $10.90.
When is next earnings date of AgeX Therapeutics Inc(AGE)?
The next earnings date of AgeX Therapeutics Inc(AGE) is 2024-05-31 Est..
Does AgeX Therapeutics Inc(AGE) pay dividends? If so, how much?
AgeX Therapeutics Inc(AGE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1